Topical Agent for Treatment of Red Skin

Mayo Clinic

Status and phase: Completed; Phase 1

Conditions: Rosacea; Bilaterally Symmetric Red Skin on Cheeks

Treatments: Drug: Topical SR-01

Study type: Interventional

Funder types: Other

Identifiers

NCT00279890

MCS 385

44-05

Details and patient eligibility

About

SR-01 may reduce facial redness. it is a topically applied product. The agent will be applied to local skin areas of subjects with red facial skin to assess affect, and then applied to the whole face to assess efficacy and safety

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Bilaterally symmetric red skin on cheeks Caucasian Age 18-60 years

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)